This course is FREE with Unlimited CE!

Choose from two Unlimited CE subscription options and get access to 750+ CE and professional development courses.

Goal and Learning Outcomes

Pediatric abusive head trauma, also known as “shaken baby syndrome,” is a severe form of child abuse that most often affects infants. Historically multiple terms have been used to describe the condition, but abusive head trauma (AHT) is now the preferred term. Shaking an infant can cause neurological injury but blunt impact is also an important cause of this injury. 
This course explains the history, challenges of diagnosis, risk factors, and long-term effects of pediatric abusive head trauma. It also explains the clinical presentation, including the mechanism of injury, characteristic and non-specific signs and symptoms along with components of a child abuse workup. 

4.7 Average

Course Reviews

799 reviews

Accreditation Information

NURSES

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

 

CEBroker

Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and  West Virginia Board Of Examiners For Registered Professional Nurses

 

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

 

Disclosures

None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.